May 24, 2023

---

Lavie Bio receives Canadian regulatory approval for its bio-inoculant seed treatment Thrivus, expanding global reach

May 18, 2023

---

Evogene reports first quarter 2023 financial results

May 9, 2023

---

Evogene's ag-seed division awarded prestigious €1.2M Horizon grant to develop oilseed crops with high CO2 assimilation and drought tolerance

March 9, 2023

---

Evogene reports fourth quarter and full year 2022 financial results

January 19, 2023

---

Casterra announces agreement with world leading energy company to cultivate its castor varieties at commercial scale

December 8, 2022

---

Evogene to receive $3.5 million payment related to patent portfolio under its existing seed traits collaboration with Bayer

November 18, 2022

---

Evogene reports third quarter 2022 financial results

October 12, 2022

---

Lavie Bio advances its novel bio-fungicide program and applies to the U.S. EPA for regulatory approval - LAV.311 is targeting fruit rots and powdery mildews fungal diseases

August 31, 2022

---

Evogene reports second quarter 2022 financial results

August 18, 2022

---

ICL and Lavie Bio enter strategic collaboration to develop novel bio-stimulant products

May 26, 2022

---

Evogene reports first quarter 2022 financial results

March 10, 2022

---

Evogene reports fourth quarter and full year 2021 financial results

December 14, 2021

---

Lavie Bio reports advancement in its bio-fungicide program for fruit rots

November 17, 2021

---

Evogene reports third quarter 2021 financial results

November 10, 2021

---

Evogene announces participation in the second research period of the CRISPR-IL Consortium - Israeli Innovation Authority to continue funding the on-going development of an end-to-end artificial intelligence system for genome-editing

November 3, 2021

---

Lavie Bio announces commercial launch of its first microbiome-based product for yield improvement under the name Result - Result inoculant initially introduced for spring wheat in North Dakota, following positive four-year field trials

September 29, 2021

---

Lavie Bio and United Agronomy announce signing of distribution agreement for Lavie Bio’s inoculant product - Commercialization targeted for 2022 for spring wheat initially

August 11, 2021

---

Evogene reports second quarter 2021 financial results

July 6, 2021

---

AgPlenus announces positive results for a herbicide resistance trait to its leading herbicide product candidate

June 23, 2021

---

Evogene announces Ms. Sarit Firon to become Evogene’s Chairperson of the Board

June 16, 2021

---

Evogene: Bullish with Canonic's entry into Israeli medical cannabis markets (Seeking Alpha)

May 26, 2021

---

Evogene reports first quarter 2021 financial results

May 25, 2021

---

Lavie Bio announces the appointment of Russ Putland as Vice President Commercial

April 5, 2021

---

Evogene files annual report for the year ended December 31, 2020

March 17, 2021

---

Plastomics and Evogene’s Ag-Seed division enter a collaborative agreement targeting novel insect control traits for soybean - The parties will test in soybean, Evogene’s candidate genes for insect control utilizing Plastomics’ novel chloroplast transformation technology

March 4, 2021

---

Evogene reports fourth quarter and full year 2020 financial results

January 5, 2021

---

Evogene Provides 2020 Year-End Update for CRISPR-IL Consortium - Progress includes completion of a first version of the artificial intelligence-driven platform for genome-editing

December 23, 2020

---

Canonic, a wholly owned subsidiary of Evogene, announces signing of first cultivation agreement for its medical cannabis varieties

December 15, 2020

---

AgPlenus announces reaching a ‘Lead’ stage in its novel mode-of-action herbicide program

November 18, 2020

---

Evogene reports third quarter 2020 financial results